Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 4;12(17):5756.
doi: 10.3390/jcm12175756.

Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver Cirrhosis

Hoor Al Kaabi  1 , Abdullah M Al Alawi  1   2 , Zubaida Al Falahi  1   2 , Zakariya Al-Naamani  2 , Said A Al Busafi  1   2   3
Affiliations

Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver Cirrhosis

Hoor Al Kaabi et al. J Clin Med. .

Abstract

Background: Chronic liver disease and cirrhosis contribute significantly to global mortality, with limited improvements despite medical advancements. This study aims to evaluate acute decompensation of liver cirrhosis characteristics, etiology, and survival outcomes in Oman. In addition, we examined the accuracy of prognostic scores in predicting mortality at 28 and 90 days.

Methods: We conducted a retrospective analysis of 173 adult patients with acute decompensation of liver cirrhosis at Sultan Qaboos University Hospital in Oman. We collected demographic, clinical, and biochemical data, including etiology, prognostic scores (CTP, MELD-Na, CLIF-C), and health outcomes.

Results: Alcohol (29.5%), hepatitis C (27.75%), and hepatitis B (26.74%) were the predominant causes of liver cirrhosis in our cohort. Hepatic encephalopathy, mechanical ventilation, and admission to the intensive care unit were strongly associated with an increased mortality rate. The 1-year readmission rate stood at 42.2%. Liver transplantation was performed in 4.1% of cases. The overall mortality rate was approximately 40% during the follow-up period, and the cumulative 28-days and 90-days mortality rates were 20.8% and 25.4%, respectively. Prognostic scores (CTP, MELD-Na, CLIF-C) effectively predicted 28- and 90-day mortality, with CLIF-C demonstrating superior performance (AUROC 0.8694 ± 0.0302 for 28-day mortality and AUROC 0.8382 ± 0.0359 for 90-day mortality).

Conclusion: Alcohol and viral hepatitis are the leading causes of liver cirrhosis in our study. Hepatic encephalopathy is a significant predictor of poor outcomes. Prognostic scores (CTP, MELD-Na, CLIF-C) have valuable predictive abilities for short-term mortality. These findings highlight the importance of public strategies to reduce alcohol consumption and the need for the comprehensive management of liver cirrhosis in Oman. Early diagnosis and intervention can improve clinical outcomes and support the establishment of a national organ transplantation program to address the healthcare challenge effectively.

Keywords: alcohol; chronic liver disease; cirrhosis; liver transplantation; organ failure; viral hepatitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier survival analysis demonstrates survival after the index admission with acute decompensated liver cirrhosis (n = 173).
Figure 2
Figure 2
Receiver operating characteristic (ROC) curve for mortality comparing prognostic scores at 28 days.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curve for mortality comparing prognostic scores at 90 days.
See this image and copyright information in PMC

References

    1. Suva M. A Brief Review on Liver Cirrhosis: Epidemiology, Etiology, Pathophysiology, Symptoms, Diagnosis and Its Management. Inven. Rapid Mol. Pharmacol. 2014;2:1–6.
    1. Sepanlou S.G., Safiri S., Bisignano C., Ikuta K.S., Merat S., Saberifiroozi M., Poustchi H., Tsoi D., Colombara D.V., Abdoli A., et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020;5:245–266. doi: 10.1016/S2468-1253(19)30349-8. - DOI - PMC - PubMed
    1. Asrani S.K., O’Leary J.G. Acute-on-chronic liver failure. Clin. Liver Dis. 2014;18:561–574. doi: 10.1016/j.cld.2014.05.004. - DOI - PMC - PubMed
    1. Ge P.S., Runyon B.A. Treatment of Patients with Cirrhosis. N. Engl. J. Med. 2016;375:767–777. doi: 10.1056/NEJMra1504367. - DOI - PubMed
    1. Angeli P., Bernardi M., Villanueva C., Francoz C., Mookerjee R.P., Trebicka J., Krag A., Laleman W., Gines P. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 2018;69:406–460. doi: 10.1016/j.jhep.2018.03.024. - DOI - PubMed

LinkOut - more resources